Barth A - Search Results

1

Pharmacokinetics of Gepotidacin in Subjects With Normal Hepatic Function and Hepatic Impairment.

Hossain M, Tiffany C, Tao Y, Barth A, Marbury TC, Preston RA, Dumont E. Hossain M, et al. Among authors: barth a. Clin Pharmacol Drug Dev. 2021 Jun;10(6):588-597. doi: 10.1002/cpdd.913. Epub 2021 Jan 15. Clin Pharmacol Drug Dev. 2021. PMID: 33450142 Free PMC article. Clinical Trial.

2

Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza.

Zuo P, Collins J, Okour M, Barth A, Shortino D, Yates P, Roberts G, Watson HA, Peppercorn A, Hossain M. Zuo P, et al. Among authors: barth a. Clin Transl Sci. 2020 Jan;13(1):157-168. doi: 10.1111/cts.12697. Epub 2019 Nov 7. Clin Transl Sci. 2020. PMID: 31664778 Free PMC article.

3

Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis).

Overcash JS, Tiffany CA, Scangarella-Oman NE, Perry CR, Tao Y, Hossain M, Barth A, Dumont EF. Overcash JS, et al. Among authors: barth a. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00199-20. doi: 10.1128/AAC.00199-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32284384 Free PMC article. Clinical Trial.

4

Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague.

Nguyen D, Shaik JS, Tai G, Tiffany C, Perry C, Dumont E, Gardiner D, Barth A, Singh R, Hossain M. Nguyen D, et al. Among authors: barth a. Br J Clin Pharmacol. 2022 Feb;88(2):416-428. doi: 10.1111/bcp.14996. Epub 2021 Sep 2. Br J Clin Pharmacol. 2022. PMID: 34289143 Free PMC article.

5

Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants.

Barth A, Hossain M, Brimhall DB, Perry CR, Tiffany CA, Xu S, Dumont EF. Barth A, et al. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0126321. doi: 10.1128/AAC.01263-21. Epub 2021 Oct 11. Antimicrob Agents Chemother. 2022. PMID: 34633853 Free PMC article. Clinical Trial.

6

Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections.

Scangarella-Oman NE, Hossain M, Hoover JL, Perry CR, Tiffany C, Barth A, Dumont EF. Scangarella-Oman NE, et al. Among authors: barth a. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0149221. doi: 10.1128/AAC.01492-21. Epub 2022 Jan 3. Antimicrob Agents Chemother. 2022. PMID: 34978887 Free PMC article. Review.

7

Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants.

Barth A, Hossain M, Perry CR, Gross AS, Ogura H, Shabbir S, Thomas S, Dumont EF, Brimhall DB, Srinivasan M, Swift B. Barth A, et al. Clin Pharmacol Drug Dev. 2023 Jan;12(1):38-56. doi: 10.1002/cpdd.1192. Epub 2022 Dec 5. Clin Pharmacol Drug Dev. 2023. PMID: 36468634 Free PMC article.

8

Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters.

Barth A, Perry CR, Shabbir S, Zamek-Gliszczynski MJ, Thomas S, Dumont EF, Brimhall DB, Nguyen D, Srinivasan M, Swift B. Barth A, et al. Clin Transl Sci. 2023 Apr;16(4):647-661. doi: 10.1111/cts.13477. Epub 2023 Jan 23. Clin Transl Sci. 2023. PMID: 36642822 Free PMC article.

9

A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease.

Mayer CL, Koeck K, Hottmann M, Redfern A, Davis M, Barth A, Geng X, Hoppe C, Yue P. Mayer CL, et al. Among authors: barth a. Eur J Clin Pharmacol. 2023 Sep;79(9):1219-1228. doi: 10.1007/s00228-023-03514-3. Epub 2023 Jul 12. Eur J Clin Pharmacol. 2023. PMID: 37436495 Free PMC article. Clinical Trial.

10

Exploring Cardiac Sympathetic Denervation as a Treatment Approach for Recurrent Ventricular Arrhythmias: A Concise Review.

Gurau A, Bosmans F, Barth A, Brock MV, Ha JS. Gurau A, et al. Among authors: barth a. J Clin Exp Cardiolog. 2024;15(3):874. Epub 2024 Mar 14. J Clin Exp Cardiolog. 2024. PMID: 39649113 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,119 results

Search Page

Filters